Cetera Investment Advisers Buys 8,612 Shares of Synopsys, Inc. $SNPS

Cetera Investment Advisers lifted its position in Synopsys, Inc. (NASDAQ:SNPS) by 24.8% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 43,346 shares of the semiconductor company’s stock after buying an additional 8,612 shares during the quarter. Cetera Investment Advisers’ holdings in Synopsys were worth $22,222,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Nuveen LLC bought a new stake in shares of Synopsys in the 1st quarter valued at about $341,480,000. Generation Investment Management LLP acquired a new position in Synopsys during the first quarter worth approximately $240,491,000. Vanguard Group Inc. raised its stake in Synopsys by 2.4% in the first quarter. Vanguard Group Inc. now owns 14,829,770 shares of the semiconductor company’s stock valued at $6,359,747,000 after buying an additional 346,994 shares during the period. Alliancebernstein L.P. raised its stake in Synopsys by 22.2% in the first quarter. Alliancebernstein L.P. now owns 1,725,211 shares of the semiconductor company’s stock valued at $739,857,000 after buying an additional 313,218 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of Synopsys by 20.2% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,816,319 shares of the semiconductor company’s stock valued at $778,928,000 after buying an additional 305,489 shares during the last quarter. 85.47% of the stock is currently owned by institutional investors and hedge funds.

Synopsys Stock Performance

Shares of NASDAQ SNPS opened at $383.82 on Wednesday. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.62 and a quick ratio of 1.51. The stock’s fifty day moving average price is $446.18 and its two-hundred day moving average price is $512.51. Synopsys, Inc. has a one year low of $365.74 and a one year high of $651.73. The firm has a market cap of $71.29 billion, a price-to-earnings ratio of 30.13, a P/E/G ratio of 5.02 and a beta of 1.10.

Synopsys (NASDAQ:SNPS) last posted its earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share for the quarter, missing analysts’ consensus estimates of $3.75 by ($1.45). Synopsys had a return on equity of 10.82% and a net margin of 31.04%.The firm had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.77 billion. During the same period in the prior year, the business posted $3.43 EPS. The firm’s quarterly revenue was up 14.0% compared to the same quarter last year. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. On average, equities analysts forecast that Synopsys, Inc. will post 10.64 EPS for the current year.

Insider Buying and Selling at Synopsys

In related news, CEO Sassine Ghazi sold 11,366 shares of the stock in a transaction that occurred on Tuesday, September 2nd. The stock was sold at an average price of $589.01, for a total transaction of $6,694,687.66. Following the sale, the chief executive officer owned 71,615 shares of the company’s stock, valued at $42,181,951.15. This represents a 13.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Shelagh Glaser sold 3,655 shares of Synopsys stock in a transaction on Friday, September 5th. The shares were sold at an average price of $609.77, for a total value of $2,228,709.35. Following the completion of the transaction, the chief financial officer directly owned 15,317 shares of the company’s stock, valued at $9,339,847.09. This represents a 19.27% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 30,894 shares of company stock worth $16,760,783. 0.62% of the stock is currently owned by company insiders.

Analyst Ratings Changes

SNPS has been the topic of a number of recent analyst reports. Weiss Ratings reissued a “hold (c)” rating on shares of Synopsys in a report on Wednesday, October 8th. Stifel Nicolaus reduced their price objective on shares of Synopsys from $650.00 to $550.00 and set a “buy” rating for the company in a research report on Wednesday, September 10th. Wells Fargo & Company dropped their price objective on shares of Synopsys from $630.00 to $550.00 and set an “equal weight” rating on the stock in a research report on Wednesday, September 10th. BNP Paribas assumed coverage on shares of Synopsys in a research note on Thursday, October 2nd. They set an “underperform” rating and a $425.00 target price for the company. Finally, The Goldman Sachs Group decreased their price target on shares of Synopsys from $700.00 to $600.00 and set a “buy” rating on the stock in a research note on Wednesday, September 10th. Nine equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat, Synopsys has a consensus rating of “Hold” and an average price target of $562.14.

Synopsys Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.